Iron and hgb
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that iron supplementation and treatment methods can impact hemoglobin levels and iron status differently depending on the population and condition, with intravenous iron showing benefits in specific cases like maternal anemia and chronic kidney disease, while additional iron in low-income infants fed iron-fortified formulas does not enhance Hgb values.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Iron and Hemoglobin: Insights from Recent Research
Iron Supplementation in Infants with Low Hemoglobin
Iron deficiency anemia remains a concern, particularly among low-income infants. A study involving 334 healthy, inner-city, minority infants aged 6 months, who were already consuming iron-fortified formulas, investigated the impact of additional iron supplementation on hemoglobin (Hgb) levels. The infants were given supplemental iron at doses of 0, 3, and 6 mg/kg per day for three months. Results showed that Hgb values increased with age regardless of iron supplementation, and there were no significant differences in mean corpuscular volume, erythrocyte porphyrins, or serum ferritin between the treatment groups. This suggests that routine iron supplementation in healthy infants fed iron-fortified formula may not be necessary.
Intravenous vs. Oral Iron for Iron-Deficiency Anemia in Pregnancy
Iron-deficiency anemia (IDA) during pregnancy can have serious consequences. A randomized controlled trial compared the effectiveness of intravenous (IV) iron versus oral iron in pregnant women with IDA. The study found that IV iron significantly reduced the rates of maternal anemia at delivery compared to oral iron. Specifically, the rate of maternal anemia (Hgb < 11 g/dL) was 40% in the IV iron group versus 85% in the oral iron group. Additionally, IV iron was associated with fewer cases of severe anemia (Hgb < 10 g/dL) and had similar rates of mild/moderate adverse reactions compared to oral iron.
Iron Supplementation in Chronic Kidney Disease
In patients with chronic kidney disease (CKD), anemia is a common issue. A study compared the effects of intravenous iron versus oral iron in anemic, iron-deficient non-dialysis CKD patients. Both forms of iron supplementation increased Hgb levels, but the increase was only significant with intravenous iron. Additionally, intravenous iron led to greater improvements in ferritin and transferrin saturation (TSAT) levels and better quality of life scores. However, intravenous iron also posed a higher risk of adverse effects such as hypotension, while oral iron was more commonly associated with constipation.
Cognitive Performance and Iron Supplementation in Children
A study conducted in Zaire, Africa, examined the impact of iron supplementation and treatment for intestinal parasites on the cognitive performance of schoolchildren. The study found that children who received both iron supplements and vermifuge treatment showed significant improvements in cognitive abilities, as measured by the Kaufman Assessment Battery for Children. This suggests that addressing iron deficiency and parasitic infections can enhance cognitive performance in children.
Iron and Hemoglobin in Parkinson’s Disease
Research has shown a correlation between elevated heme oxygenase-1 (HO-1) levels, increased brain iron deposition, and decreased Hgb levels in patients with Parkinson’s disease (PD). The study found that higher serum HO-1 concentrations were associated with greater iron deposition in specific brain regions and lower Hgb levels. This indicates that HO-1 may play a role in the common mechanisms underlying iron deposition and anemia in PD.
Iron Status Markers and Hemoglobin in Children with CKD
In children with chronic kidney disease, serum ferritin and TSAT are commonly used to assess iron status. A study involving 304 children with mild-to-moderate CKD found that lower glomerular filtration rate (GFR), low serum iron, and high ferritin levels were strongly associated with lower Hgb percentiles. This suggests that these markers can help identify children at risk of lower Hgb values and guide iron supplementation strategies.
Impact of Mild Infections on Iron Deficiency in Infants
Mild infections can influence iron status and Hgb levels in infants. A study of 467 healthy term infants found that those with recent infections were more likely to have anemia or low-normal Hgb levels. The study also showed that infants with prior infections had a higher Hgb response to iron treatment compared to those without infections. This indicates that mild infections may predispose infants to iron deficiency by affecting iron absorption .
Conclusion
The research highlights the complex interplay between iron supplementation, hemoglobin levels, and various health conditions. While iron supplementation can be beneficial in specific populations, such as pregnant women with IDA and children with CKD, its routine use in healthy infants fed iron-fortified formulas may not be necessary. Additionally, addressing underlying conditions such as infections and parasitic infestations can significantly improve iron status and cognitive performance. Understanding these nuances is crucial for optimizing iron supplementation strategies and improving health outcomes.
Sources and full results
Most relevant research papers on this topic
